Edwards Lifesciences Q4 2022 Earnings Preview

Jan. 30, 2023 5:35 PM ETEdwards Lifesciences Corporation (EW)By: Dania Nadeem, SA News Editor
  • Edwards Lifesciences (NYSE:EW) is scheduled to announce Q4 earnings results on Tuesday, January 31st, after market close.
  • The consensus EPS Estimate is $0.61 (+19.6% Y/Y) and the consensus Revenue Estimate is $1.33B (flat Y/Y).
  • Over the last 2 years, EW has beaten EPS estimates 50% of the time and has beaten revenue estimates 63% of the time.
  • Over the last 3 months, EPS estimates have seen 0 upward revisions and 20 downward. Revenue estimates have seen 0 upward revisions and 18 downward.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.